Abstract
MIRO2/GCN1/GCN2 constitute a novel mitochondrial signaling pathway that controls androgen-independent and androgen-sensitive prostate cancer cell growth.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have